146 related articles for article (PubMed ID: 2287055)
1. [A double-blind comparative study of S 6472 (a long-acting cefaclor) versus a conventional cefaclor preparation in complicated urinary tract infections].
Arakawa S; Takagi S; Matsumoto O; Kamidono S; Hirooka K; Hamami G; Matsumoto H; Saito H; Umezu K; Ishigami J
Jpn J Antibiot; 1990 Nov; 43(11):1873-92. PubMed ID: 2287055
[TBL] [Abstract][Full Text] [Related]
2. [Comparative studies of the efficacy, safety and usefulness of S6472, cefaclor and cephalexin on complicated urinary tract infection by the double-blind method].
Kamidono S; Arakawa S; Fujii A; Kataoka N; Umezu K; Ishigami J; Hirooka K; Shimatani N; Matsushita M; Hikosaka K
Jpn J Antibiot; 1985 Oct; 38(10):2735-69. PubMed ID: 3908727
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of S6472 (prolonged action preparation of cefaclor) in the treatment of skin and soft tissue infections. A double blind comparison of S6472 and cefaclor].
Sakai K; Fujimoto M; Ueda T; Yura J; Shinagawa N; Ishikawa S; Tachi Y; Kobe A; Shibata Y; Doi S
Jpn J Antibiot; 1985 Oct; 38(10):2716-34. PubMed ID: 3908726
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of BMY-28100 for bacterial pneumonia in comparison with cefaclor in a double-blind study].
Oizumi K; Watanabe A; Saito A; Tomizawa M; Nakayama I; Hiraga Y; Ohmichi M; Tamura M; Konishi K; Gomi K
Jpn J Antibiot; 1990 Nov; 43(11):1914-47. PubMed ID: 2287058
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
Yura J; Shinagawa N; Mizuno A; Watanabe S; Ando M; Sakai K; Ueda T; Morimoto K; Nakamura T; Hashimoto I
Jpn J Antibiot; 1988 Oct; 41(10):1517-37. PubMed ID: 3060626
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of sustained release preparations of cefaclor in dental infections. Comparative double blind clinical studies of sustained release preparations with a regular preparation of cefaclor].
Horii M; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Inaba O; Takada S; Kimura J
Jpn J Antibiot; 1985 Apr; 38(4):1117-40. PubMed ID: 3897614
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study of S 6472 in urinary tract infection].
Takagi S; Arakawa S; Matsumoto O; Kamidono S; Hirooka K; Hamami G; Ishigami J; Umezu K; Yamanaka N; Sugimoto M
Jpn J Antibiot; 1990 Nov; 43(11):1850-72. PubMed ID: 2287054
[TBL] [Abstract][Full Text] [Related]
8. [A double-blind comparative study on the efficacy of S6472, cefaclor, in the treatment of bacterial bronchitis].
Oshima S; Yokoyama Y; Kikuiri T; Murakami T; Nishihara H; Shimizu T; Abe M; Kurihara Y; Itoh C; Takeuchi K
Jpn J Antibiot; 1986 Oct; 39(10):2726-53. PubMed ID: 3543432
[TBL] [Abstract][Full Text] [Related]
9. [A double blind controlled study on S6472 capsules and granules in complicated urinary tract infection].
Arakawa S; Matsui T; Tanaka K; Ishigami J; Kamidono S; Ito N; Tanaka H; Hasunuma Y; Omae H; Shinozaki M
Jpn J Antibiot; 1994 Feb; 47(2):195-209. PubMed ID: 8151912
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of cefuroxime axetil in acute dental infections. Double blind comparative study vs. cefaclor].
Sasaki I; Morihana T; Kaneko A; Michi K; Takahashi K; Fukuoka F; Satoh T; Yoshinari N; Ohne M; Hara H
Jpn J Antibiot; 1990 Dec; 43(12):2035-68. PubMed ID: 2086820
[TBL] [Abstract][Full Text] [Related]
11. [Study of finding the optimum dose of cefetamet pivoxil in complicated urinary tract infections].
Ohmori H; Kumon H; Kanemasa Y; Hirai Y; Saito T
Jpn J Antibiot; 1990 Dec; 43(12):2102-32. PubMed ID: 2086824
[TBL] [Abstract][Full Text] [Related]
12. [A double blind comparative study on the efficacy of S6472, cefaclor and amoxicillin, in the treatment of bacterial pneumonia].
Shibaki H; Chimoto T; Nakabayashi T; Ishii Y; Tosaka M; Watanabe H; Onodera S; Shimizu T; Sasaki N; Ikeda Y
Jpn J Antibiot; 1986 Mar; 39(3):853-86. PubMed ID: 3525883
[TBL] [Abstract][Full Text] [Related]
13. [A double-blind comparison between cefaclor and cephalexin in the treatment of dental infections].
Horii M; Morinaga T; Takeuchi T; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Takada S
Jpn J Antibiot; 1984 Jan; 37(1):152-75. PubMed ID: 6374193
[TBL] [Abstract][Full Text] [Related]
14. [Effect of cefaclor in urinary tract infections (2)].
Kajikawa H; Hosokawa S; Kameoka H; Nishimoto N; Miyoshi S; Iwao N; Mizutani S
Jpn J Antibiot; 1984 Aug; 37(8):1453-69. PubMed ID: 6502932
[TBL] [Abstract][Full Text] [Related]
15. [Clinical studies of S6472 in otorhinolaryngologic infections].
Baba S; Kinoshita H; Mori Y; Suzuki K; Ohyama M; Katsuta K; Furuta S; Ohno I; Noboru T; Yamamoto M
Jpn J Antibiot; 1985 Jul; 38(7):1750-60. PubMed ID: 4068219
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study on intravenous drip infusion of dibekacin once daily and twice daily in treatment of complicated urinary tract infections].
Kishi H; Kaneco H; Tominaga T; Niijima T; Nishimura Y; Saito I; Ishii Y; Nito H; Yuge J; Asano M
Hinyokika Kiyo; 1984 Jan; 30(1):103-20. PubMed ID: 6375317
[TBL] [Abstract][Full Text] [Related]
17. [A parallel comparative double blind study of cefixime with cefaclor in the treatment of acute suppurative otitis media in children].
Baba S; Kinoshita H; Mori Y; Suzuki K; Shimada J; Kawamura S; Onishi S; Ueda R; Kobayashi K; Itoh Y
Jpn J Antibiot; 1987 Jan; 40(1):1-24. PubMed ID: 3295321
[TBL] [Abstract][Full Text] [Related]
18. [Fundamental and clinical studies on S6472 (a new prolonged acting preparation of cefaclor) in the urological field].
Kamidono S; Fujii A; Harada M; Arakawa S; Umezu K; Kataoka N; Ishigami J; Hirooka K; Shimatani N; Matsushita M
Jpn J Antibiot; 1985 Mar; 38(3):869-904. PubMed ID: 3928939
[TBL] [Abstract][Full Text] [Related]
19. [Clinical results of cefaclor treatment of infections of oral regions].
Yoshida Y; Kita T; Kanematsu N; Sato K; Kawata K; Fukuta N; Sato J
Jpn J Antibiot; 1984 Mar; 37(3):318-28. PubMed ID: 6737694
[TBL] [Abstract][Full Text] [Related]
20. Cefprozil versus cefaclor in the treatment of acute and uncomplicated urinary tract infections. Cefprozil Multicenter Study Group.
Iravani A; Doyle CA; Durham SJ; Wilber RB
Clin Ther; 1992; 14(2):314-26. PubMed ID: 1611652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]